Nirmatrelvir-ritonavir for outpatients with COVID-19. Case-based approach to assessment and treatment

被引：0
|
作者：
LeBras, Marlys [1 ]
Crawley, Alex [2 ]
Legge, Marc [3 ]
Takaya, Satchan [4 ]
Lee, Stephen [5 ]
Regier, Loren [3 ]
机构：
[1] Univ Saskatchewan, Programme Format Continue Pharmacotherapie, Saskatoon, SK, Canada
[2] Univ Saskatchewan, Programme Format Continue Pharmacotherapie RxFile, Saskatoon, SK, Canada
[3] Programme Format Continue Pharmacotherapie, Saskatoon, SK, Canada
[4] Univ Saskatchewan, Coll Med, Div Malad Infect, Saskatoon, SK, Canada
[5] Univ Saskatchewan, Coll Med, Malad Infect & Med Interne, Saskatoon, SK, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2023年 / 69卷 / 08期
关键词：
D O I：
10.46747/cfp.6908e170
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：E170 / E174
页数：5
相关论文
共 50 条
  • [21] Nirmatrelvir-ritonavir treatment of COVID-19 in a high-risk patient population: A retrospective observational study
    Kane, Anna M.
    Keenan, Erica M.
    Lee, Kasheng
    Hartkopf, Katherine J.
    Ludwig, Trisha A.
    Trapskin, Philip J.
    Vanderloo, Joshua P.
    Schulz, Lucas T.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2023, 6 (01): : 29 - 33
  • [22] Nirmatrelvir-Ritonavir (Paxlovid) for Mild Coronavirus Disease 2019 (COVID-19) in Pregnancy and Lactation
    Lin, Christine Y.
    Cassidy, Arianna G.
    Li, Lin
    Prahl, Mary K.
    Golan, Yarden
    Gaw, Stephanie L.
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (05): : 957 - 960
  • [23] Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis
    Chen, I-Wen
    Yu, Ting-Sian
    Lin, Chien-Hung
    Hung, Kuo-Chuan
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (06)
  • [24] Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19
    Zhang, Huan
    Tan, Xiaojiao
    Chen, Junjun
    Zhang, Zheng
    Wang, Chenxi
    Shi, Haiqing
    Li, Yao
    Li, Jianbo
    Kang, Yan
    Jin, Xiaodong
    Liao, Xuelian
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [25] COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment A Randomized Clinical Trial
    Yang, Zhitao
    Xu, Yu
    Zheng, Ruizhi
    Ye, Lei
    Lv, Gang
    Cao, Zhujun
    Han, Rulai
    Li, Mian
    Zhu, Yuanyue
    Cao, Qiuyu
    Ding, Yi
    Wang, Jiqiu
    Tan, Yun
    Liu, Feng
    Wei, Dong
    Tan, Wei
    Jiang, Weiwei
    Sun, Jing
    Sun, Shouyue
    Shao, Jie
    Deng, Yang
    Gao, Weiyi
    Wang, Weiqing
    Zhao, Ren
    Qiu, Liping
    Chen, Erzhen
    Zhang, Xinxin
    Wang, Shengyue
    Ning, Guang
    Xu, Yiping
    Bi, Yufang
    JAMA NETWORK OPEN, 2024, 7 (03) : E241765
  • [26] Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer
    Liu, Catherine
    Yoke, Leah H.
    Bhattacharyya, Pooja
    Cassaday, Ryan D.
    Cheng, Guang-Shing
    Escobar, Zahra Kassamali
    Ghiuzeli, Cristina
    McCulloch, Denise J.
    Pergam, Steven A.
    Roychoudhury, Pavitra
    Tverdek, Frank
    Schiffer, Joshua T.
    Ford, Emily S.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (06):
  • [27] A Case Report of Safe Coadministration of Amiodarone with Short-Term Treatment Nirmatrelvir-Ritonavir
    Sluijters, Alice
    Lemaitre, Florian
    Belkhir, Leila
    Boland, Lidvine
    Haufroid, Vincent
    De Greef, Julien
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (04) : 768 - 769
  • [28] SAFETY ASSESSMENT OF NIRMATRELVIR-RITONAVIR IN THE FDA ADVERSE EVENT REPORTING SYSTEM: A DATA MINING APPROACH
    Teng, C.
    Lu, K. Z.
    VALUE IN HEALTH, 2024, 27 (06) : S155 - S155
  • [29] Population-based evaluation of the effectiveness of nirmatrelvir-ritonavir for reducing hospital admissions and mortality from COVID-19
    Schwartz, Kevin L.
    Wang, Jun
    Tadrous, Mina
    Langford, Bradley J.
    Daneman, Nick
    Leung, Valerie
    Gomes, Tara
    Friedman, Lindsay
    Daley, Peter
    Brown, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (06) : E220 - E226
  • [30] Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19
    Zeng, Guangting
    Wang, Linlin
    Li, Jianqiang
    Zhang, Zanling
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
12345